| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 69, 1122-1126, Copyright © 1989 by Endocrine Society
ARTICLES |
GF Pieters, AR Hermus, E Meijer, AG Smals and PW Kloppenborg
Department of Medicine, University Hospital Nijmegen, The Netherlands.
Twenty-seven patients with Cushing's disease underwent transsphenoidal pituitary surgery. After the operation 16 patients were cured, and 11 remained hypercortisolemic. In the cured patients a significantly lower incidence of paradoxical responsiveness to TRH or to LRH was found preoperatively (1 of 16) than in the failures (6 of 11; P less than 0.02, by Fisher's chi 2 test). Furthermore, responsiveness of cortisol to CRH administration was significantly lower in the failures [maximum, 0.30 +/- 0.10 mumol/L (10.8 +/- 3.6 micrograms/dL) vs. 0.50 +/- 0.07 mumol/L (18.1 +/- 2.5 micrograms/dL) in the cured patients; P less than 0.05]. There were no differences in basal plasma cortisol levels, ACTH levels, or suppressibility by dexamethasone between the 2 groups. In the 16 patients who were cured initially, 4 patients relapsed after a mean period of 4 yr. These 4 patients had significantly higher basal cortisol levels postoperatively than those who remained in remission [0.14 +/- 0.03 mumol/L (5.1 +/- 0.8 micrograms/dL) vs. 0.04 +/- 0.01 mumol/L (1.4 +/- 0.3 micrograms/dL); P less than 0.01]. Cortisol responses to CRH after the operation positively correlated with the basal cortisol levels at that time (P less than 0.05, by Spearman's rank correlation test; r = 0.64), thus, the relapsing patients had higher cortisol responses to CRH than patients who stayed in remission [maximum response, 0.31 +/- 0.07 (11.2 +/- 2.5 micrograms/dL) vs. 0.12 +/- 0.03 mumol/L (4.3 +/- 1.1 microgram/dL), respectively; P less than 0.05]. We conclude that 1) patients responding paradoxically to TRH and/or LRH have a lower chance of being cured after pituitary surgery; and 2) patients with higher cortisol levels (greater than 0.10 mumol/L; 3.6 micrograms/dL) after being cured initially have a higher chance of recurrence of their disease.
This article has been cited by other articles:
![]() |
C. G. Patil, D. M. Prevedello, S. P. Lad, M. L. Vance, M. O. Thorner, L. Katznelson, and E. R. Laws Jr. Late Recurrences of Cushing's Disease after Initial Successful Transsphenoidal Surgery J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 358 - 362. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Pouratian, D. M. Prevedello, J. Jagannathan, M. B. Lopes, M. L. Vance, and E. R. Laws Jr. Outcomes and Management of Patients with Cushing's Disease without Pathological Confirmation of Tumor Resection after Transsphenoidal Surgery J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3383 - 3388. [Abstract] [Full Text] [PDF] |
||||
![]() |
R T Netea-Maier, E J van Lindert, M den Heijer, A van der Eerden, G F F M Pieters, C G J Sweep, J A Grotenhuis, and A R M M Hermus Transsphenoidal pituitary surgery via the endoscopic technique: results in 35 consecutive patients with Cushing's disease. Eur. J. Endocrinol., May 1, 2006; 154(5): 675 - 684. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Hammer, J. B. Tyrrell, K. R. Lamborn, C. B. Applebury, E. T. Hannegan, S. Bell, R. Rahl, A. Lu, and C. B. Wilson Transsphenoidal Microsurgery for Cushing's Disease: Initial Outcome and Long-Term Results J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6348 - 6357. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. F. S. Rollin, N. P. Ferreira, M. Junges, J. L. Gross, and M. A. Czepielewski Dynamics of Serum Cortisol Levels after Transsphenoidal Surgery in a Cohort of Patients with Cushing's Disease J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1131 - 1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Estrada, J. Garcia-Uria, C. Lamas, J. Alfaro, T. Lucas, S. Diez, L. Salto, and B. Barcelo The Complete Normalization of the Adrenocortical Function as the Criterion of Cure after Transsphenoidal Surgery for Cushing's Disease J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5695 - 5699. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Invitti, F. P. Giraldi, M. De Martin, and F. Cavagnini Diagnosis and Management of Cushing's Syndrome: Results of an Italian Multicentre Study J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 440 - 448. [Abstract] [Full Text] |
||||
![]() |
D. J. Devoe, W. L. Miller, F. A. Conte, S. L. Kaplan, M. M. Grumbach, S. M. Rosenthal, C. B. Wilson, and S. E. Gitelman Long-Term Outcome in Children and Adolescents after Transsphenoidal Surgery for Cushing's Disease J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3196 - 3202. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Estrada, M. Boronat, M. Mielgo, R. Magallon, I. Millan, S. Diez, T. Lucas, and B. Barcelo The Long-Term Outcome of Pituitary Irradiation after Unsuccessful Transsphenoidal Surgery in Cushing's Disease N. Engl. J. Med., January 16, 1997; 336(3): 172 - 177. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |